Crohn's disease: beyond antagonists of tumour necrosis factor (original) (raw)
Tumor Necrosis Factor’s Pathway in Crohn’s Disease: Potential for Intervention
Fabio Cominelli
International Journal of Molecular Sciences, 2021
View PDFchevron_right
Update on anti-tumor necrosis factor agents in Crohn disease
Siddharth Singh
Gastroenterology clinics of North America, 2014
View PDFchevron_right
AntiTumor Necrosis Factor-Alpha (TNF-α) Treatment Strategies in Crohn's Disease
Christian D Muller
Recent Patents on Inflammation & Allergy Drug Discovery, 2007
View PDFchevron_right
Crohn's disease: future anti–tumor necrosis factor therapies beyond infliximab
Joshua Korzenik
Gastroenterology Clinics of North America, 2004
View PDFchevron_right
Optimizing the Use of Tumour Necrosis Factor Inhibitors in Crohnʼs Disease
Maria Etchevers
Drugs, 2010
View PDFchevron_right
Crohn’s Disease Biologic Therapies Advances: A current review
Jorge Balteiro
2017
View PDFchevron_right
Anti-Tumor Necrosis Factor-Alpha (TNF-α) Treatment Strategies in Crohns Disease
Brigitte Sola
Recent Patents on Inflammation & Allergy Drug Discovery, 2007
View PDFchevron_right
Review article: biological agents in the treatment of Crohn's disease
Angelo Viscido
Alimentary Pharmacology & Therapeutics
View PDFchevron_right
Recommendations for the treatment of Crohnʼs disease with tumor necrosis factor antagonists: An expert consensus report
Dario Sorrentino
Inflammatory Bowel Diseases, 2012
View PDFchevron_right
Novel strategies to attenuate immune activation in Crohn's disease
Giorgos Bamias
Current Opinion in Pharmacology, 2006
View PDFchevron_right
Biological agents in the treatment of Crohn's disease
Angelo Viscido
Alimentary Pharmacology and Therapeutics, 2002
View PDFchevron_right
An engineered human antibody to TNF (CDP571) for active Crohn's disease: a randomized double-blind placebo-controlled trial
William Sandborn
Gastroenterology, 2001
View PDFchevron_right
Role of the tumor necrosis factor antagonists in the treatment of inflammatory bowel disease: an update
Lorenzo Leggio
European Journal of Gastroenterology & Hepatology, 2010
View PDFchevron_right
Infliximab induces potent anti-inflammatory and local immunomodulatory activity but no systemic immune suppression in patients with Crohn's disease
J. Ceuppens, K. Geboes
Alimentary Pharmacology and Therapeutics, 2001
View PDFchevron_right
Potential therapeutic role for cytokine or adhesion molecule manipulation in Crohn's disease: in the shadow of infliximab?
Alastair Forbes
International Journal of Colorectal Disease, 2003
View PDFchevron_right
Anti-tumor necrosis factor treatment restores the gut barrier in Crohn's disease
Benny Geypens
The American journal …, 2002
View PDFchevron_right
CDP571, a Humanized Anti-Tumor Necrosis Factor-α Monoclonal Antibody in Pediatric Crohn’s Disease
Jatin Patel
Inflammatory Bowel Diseases, 2004
View PDFchevron_right
Antitumor necrosis factor therapy for inflammatory bowel disease: a review of agents, pharmacology, clinical results, and safety
William Sandborn
Inflammatory bowel diseases, 1999
View PDFchevron_right
Novel therapies for Crohn’s disease
Ioannis Koutroubakis
View PDFchevron_right
Biological Therapy in the Prevention of Complications of Crohn
Dolores Ortiz
Biological Therapy for Inflammatory Bowel Disease, 2020
View PDFchevron_right
Do anti-tumor necrosis factors induce response and remission in patients with acute refractory Crohn's disease? A systematic meta-analysis of controlled clinical trials
Shekoufeh Nikfar
Biomedecine & Pharmacotherapy, 2007
View PDFchevron_right
Inflammatory Cytokine Profile in Crohn's Disease Nonresponders to Optimal Antitumor Necrosis Factor Therapy
Anjali Jain
Journal of clinical gastroenterology, 2018
View PDFchevron_right
A randomized, double‐blind, placebo‐controlled trial of CDP571, a humanized monoclonal antibody to tumour necrosis factor‐α, in patients with corticosteroid‐dependent Crohn's disease
Bruce Salzberg MD, FACG
Alimentary Pharmacology & Therapeutics, 2005
View PDFchevron_right
Biologics in inflammatory bowel disease: how much progress have we made?
William Sandborn
Gut, 2004
View PDFchevron_right
Biologic therapies in inflammatory bowel disease
Manuela Neuman
Translational Research, 2014
View PDFchevron_right
A critical approach to new forms of treatment of Crohn's disease and ulcerative colitis
Amado Salvador Peña
Alimentary Pharmacology & Therapeutics, 2002
View PDFchevron_right
The Influence of Innate and Adaptive Immunity on Crohn’s Disease Severity
Keith Sacco
Journal of Clinical & Cellular Immunology, 2014
View PDFchevron_right
Inhibitors of Tumoral Necrosis Factor Alpha in Inflammatory Bowel Disease
Carlos Walter Sobrado
Biological Therapy for Inflammatory Bowel Disease, 2020
View PDFchevron_right
Loss of Response to Anti-Tumor Necrosis Factor Alpha Therapy in Crohn's Disease Is Not Associated with Emergence of Novel Inflammatory Pathways
Suraj Patel
Digestive diseases and sciences, 2018
View PDFchevron_right
Real world analysis on the efficacy and safety of anti-tumor necrosis factor therapy in patients with stricturing Crohn’s disease
Govind Makharia
Scientific Reports, 2021
View PDFchevron_right
Inflammatory Bowel Disease: An Overview of Immune Mechanisms and Biological Treatments
Bruno de Mattos
Mediators of Inflammation, 2015
View PDFchevron_right
Preclinical Development of a Novel, Orally-Administered Anti-Tumour Necrosis Factor Domain Antibody for the Treatment of Inflammatory Bowel Disease
Luis Miguel Mendoza
Scientific reports, 2018
View PDFchevron_right
Clinical profiles of moderate and severe Crohn's disease patients and use of anti-tumor necrosis factor agents: Greek expert consensus guidelines
Gerassimos Mantzaris
Annals of gastroenterology : quarterly publication of the Hellenic Society of Gastroenterology
View PDFchevron_right
Review Article Inflammatory Bowel Disease: An Overview of Immune Mechanisms and Biological Treatments
Bruno de Mattos
Mediators of Inflammation
View PDFchevron_right
Infliximab induced T lymphocyte apoptosis in Crohn's disease
Maikel Peppelenbosch
The Journal of rheumatology. Supplement, 2005
View PDFchevron_right